FENC vs HUBS · rev $17.9M vs P/E 96, rev $1.79B
Fennec Pharmaceuticals Inc (FENC) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
FENC currently screens at market cap $302.2M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the FENC and HUBS stock pages for the full models.
Not investment advice.